Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Counterfeit med market grows worldwide

DQSA to help address global counterfeit drug market, recently estimated at more than $430 billion annually by the WHO.

Shown in this photo is a fake Lamisil three-pack.
Shown in this photo is a fake Lamisil three-pack.

A blog on USDM Life Sciences’ website says, “Getting a prescription filled at a cheaper online pharmacy is tempting for many of us. But, if your online pharmacy is not verified, there’s a chance you are being ripped off or worse yet, putting your life in danger.”

USDM’s blog points out, “In many cases, the drugs do not have their intended ingredients in them. Patients who unknowingly obtain and use the counterfeit drugs are not getting the medical treatment they need and many unsuspecting patients are dying from the counterfeit medicines.”

A late Sept. 2013 report on google.com said that the World Health Organization estimated that the “worldwide market for counterfeit drugs topped $430 billion a year.”

Counterfeit medications are not new, yet remain alarming. For example, TheCounterfeitReport.com reports that Novartis is investigating over-the-counter “Lamisil” anti-fungal antibiotic medications sold on sites such as Amazon and eBay product that are not part of the Novartis product line and whose ingredients are unknown. Authentic and fake Lamisil products are shown on TheCounterfeitReport.com’s website.

Visit that site’s “Counterfeit Products In The News” page and you can read stories with headlines that range from “Counterfeit Medicines: The New Face Of Organized Crime” to  “Hezbollah Maintains Network of Companies Trading in Counterfeit Medicine” to “Fake Flu Medicine Does Nothing, Or Worse.” Disturbing news, to be sure.

What could help is the recently signed into law, H.R. 3204, known also as the Drug Quality and Security Act.

Circling back to the USDM blog, the DQSA law “means pharmaceutical companies will have to adopt a track-and-trace system for their medicines. Individual packs of drugs will need serial numbers within four years of the bill becoming law, which is November 27, 2017. In 10 years, medicine will need to be traceable as it makes its way from the manufacturer to a pharmacy.”

Coding, Marking, and Labeling Innovations Report
Explore our editor-curated report featuring cutting-edge coding, labeling, and RFID innovations from PACK EXPO 2024. Discover high-speed digital printing, sustainable label materials, automated labeling systems, and advanced traceability solutions that are transforming packaging operations across industries.
Access Report
Coding, Marking, and Labeling Innovations Report
2024 PACK EXPO Innovations Reports
Exclusive access: Packaging World editor-curated reports revealing PACK EXPO's most groundbreaking technologies across food, healthcare, and machinery sectors. Each report features truly innovative solutions selected from hundreds of exhibitors by our expert team. Transform your operations with just one click.
Access Now
2024 PACK EXPO Innovations Reports